[BLlogo7.gif]

Bloodline

Home
About
Call for Papers
Free Membership
Search

XML icon

Educational Features

Image Atlas
Case Studies
Private Lectures
Conference Reviews
Journal Articles
Book Reviews
Glossary


Resources

Conference Calendar
Grants & Fellowships
Hematology Links
BMT Reviews
Classifieds


Specialties

BMT/Stem Cell
Cord Blood
Thrombosis
Hemostasis
Laboratory
Malignancies
Pediatrics
Red Cell Disorders
Infections
Transfusion Medicine
Veterinary


websel.gif:

toprated.gif:

HLA-C and Marrow Graft Rejection

Generation of HLA-C-Specific Cytotoxic T Cells in Association With Marrow Graft Rejection: Analysis of Alloimmunity by T-Cell Cloning and Testing of T-Cell-Receptor Rearrangements

Ji Pei, Yoshiki Akatsuka, Claudio Anasetti, Ming-Tseh Lin, Effie W. Petersdorf, John A. Hansen, Paul J. Martin

Biology of Blood and Marrow Transplantation 7:378-383
© 2001 American Society for Blood and Marrow Transplantation

Peripheral blood mononuclear cells from a patient who rejected a T-cell-depleted marrow graft showed spontaneous cytotoxic activity specific for HLA-Cw4 and HLA-B35 alloantigens of the donor. T-cell-receptor complementarity-determining region 3 length distributions in a blood sample obtained at the time of rejection generally showed distortions in only 1 or 2 peaks, indicating that recipient T cells with a broad repertoire of antigen receptors survived the pretransplantation conditioning regimen. An HLA-Cw4-specific, CD8+ T-cell clone was recovered from a blood sample after rejection. The T-cell-receptor-B gene rearrangement expressed by this clone was not readily detectable in other blood samples drawn before or after the transplantation, indicating that this clone was only 1 of many recipient-derived T cells that recognized HLA alloantigens of the donor. These results demonstrate the role of the HLA-C locus in T-cell-mediated alloimmune responses and add to emerging evidence that indicates the need to evaluate HLA-C compatibility in selecting hematopoietic stem cell donors for patients who have an increased risk of rejection.

pdficon.gif: Download the full article.


sm_cjpLogo.gifCopyright 1995-2010 - Carden Jennings Publishing Co., Ltd. All rights reserved. The material available at this site is for educational purposes only and is NOT intended for any diagnostic, clinically related, or other purpose. Carden Jennings Publishing Co., Ltd., assumes no responsibility for any use or misuse of this material and makes no warranty or representation of any kind with respect to the material available at this site.

Featured Resources



Multiple Myeloma: A Practical Guide to Current Management

TOCpic.jpg:
BloodLine Image Atlas